Trials / Completed
CompletedNCT03670680
Efficiency of Lina LibrataTM System
Evaluation of the Efficiency of Lina LibrataTM System in the Treatment of Functional Idiopathic Menometrorrhagia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- Female
- Age
- 38 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
Menometrorrhagia is the first cause of consultation in gynecology. Etiology of menometrorrhagia is varied, but in majority of cases no underlying pathology is found, they are said functional idiopathic menometrorrhagia . In case of failure of medical treatment, for women who do not wish to preserve reproduction possibilities, a surgical treatment by endometrectomy (destruction of the uterine endometrial epithelial) can be proposed. Currently, a new system, Lina LibrataTM is available on the market. This system allows destructing endometrial membrane with a balloon which offer several advantages compared to present used system. Specially, it does not require dilatation of uterus's cervix and it reduces the pain. The investigator make hypothesis that the use of the system Lina LibrataTM does not cause pain and can be thus used under local anesthetic in ambulatory surgery. With the aim of developing ambulatory care, the main objective of this prospective monocentric study is to estimate the efficiency of Lina LibrataTM system in the treatment of functional idiopathic menometrorrhagia. Secondary objectives are to estimate the pain during the procedure, the rate of per and post-complications and quality of life.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Use of the Lina LibrataTM | Use of the Lina LibrataTM |
Timeline
- Start date
- 2018-10-16
- Primary completion
- 2025-09-30
- Completion
- 2025-09-30
- First posted
- 2018-09-13
- Last updated
- 2026-01-22
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03670680. Inclusion in this directory is not an endorsement.